We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$2.3B
AUM Growth
+$180M
Cap. Flow
+$36.1M
Cap. Flow %
1.57%
Top 10 Hldgs %
24.59%
Holding
207
New
29
Increased
53
Reduced
82
Closed
32

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$55.8M
2
PPG icon
PPG Industries
PPG
+$23.4M
3
DE icon
Deere & Co
DE
+$17.4M
4
ICE icon
Intercontinental Exchange
ICE
+$14.9M
5
ARES icon
Ares Management
ARES
+$11.5M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Financials 17.36%
3 Healthcare 14.58%
4 Consumer Discretionary 9.33%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCOM icon
201
Trip.com Group
TCOM
$29.5B
-70,900
Closed -$2.67M
UGI icon
202
UGI
UGI
$7.72B
-17,925
Closed -$623K
URI icon
203
United Rentals
URI
$67.4B
-1,787
Closed -$707K
VRTX icon
204
Vertex Pharmaceuticals
VRTX
$121B
-3,448
Closed -$1.09M
VZ icon
205
Verizon
VZ
$194B
-1,688
Closed -$65.6K
WBS icon
206
Webster Financial
WBS
$12.5B
-24,265
Closed -$957K
CNH
207
CNH Industrial
CNH
$12.8B
-299,392
Closed -$4.58M

Similar funds

Meag Munich Ergo's Q2 2023 Portfolio in Review

As of Q2 2023, Meag Munich Ergo held 207 positions worth $2.3B, up 8.5% from $2.11B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Meag Munich Ergo's Q2 2023 filing shows 29 new, 53 increased, 82 reduced and 32 closed positions. Its largest new stake was Emerson Electric: 357,262 shares worth $32.3M. The largest sale was Eli Lilly, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Meag Munich Ergo's largest Q2 2023 buy was Emerson Electric: 357,262 shares worth $32.3M.
  • Meag Munich Ergo added most to Gilead Sciences in Q2 2023, an estimated $38.6M increase.
  • Meag Munich Ergo's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $55.8M.
  • Meag Munich Ergo fully exited Deere & Co in Q2 2023, selling an estimated $17.4M.
  • Meag Munich Ergo's ten largest holdings make up 25% of its $2.3B portfolio in Q2 2023.
  • Meag Munich Ergo opened 29 new positions and closed 32 in Q2 2023.
  • Meag Munich Ergo's portfolio value rose 8.5% quarter-over-quarter to $2.3B.

Based on Meag Munich Ergo's 13F filing for Q2 2023, filed 14 Jul 2023.